Anti-TMEM14A antibodies are used in the immunodetection of the protein transmembrane protein 14A. In humans, the canonical protein has a reported length of 99 amino acid residues and a mass of 10.7 kDa. Its subcellular localization is in the mitochondria and ER. It is noted to be expressed at significantly higher levels in ovarian cancer tissues than in normal tissues. A member of the TMEM14 protein family, TMEM14A is reported to inhibit apoptosis via negative regulation of the mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway. Synonyms for this target antigen include C6orf73 and PTD011. TMEM14A gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some TMEM14A antibodies may have been used in research and have associated citations. ELISA is a widely used application for these antibodies. In addition, Western Blot is also a common application.